Colorado Adult Joint Assessment Scale (CAJAS) Validation

Bayer30 enrolled

Overview

To obtain evidence of content validity and reliability of the Colorado Adult Joint Assessment Scale (CAJAS), a clinician-reported outcome (ClinRO) measure, as adapted for use in a population of adults with moderate to severe hemophilia A treated with coagulation factor VIII (FVIII) therapy as secondary prophylaxis or episodic treatment.

Study Type

INTERVENTIONAL

Allocation

Masking

NONE

Enrollment

Conditions

Hemophilia A

Interventions

Colorado Adult Joint Assessment EvaluationOTHER

Physical evaluation of 6 joints, ankles, knees and elbows

Eligibility

Sex: MALEMin age: 18 YearsMax age: 50 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Male, 18 to 50 years of age * Diagnosis of moderate to severe hemophilia A (documented \<1-2% Factor VIII Concentration \[FVIII:C\]) * Willing to maintain current FVIII treatment regimen, whether prophylactic or on-demand, for the duration of the study Exclusion Criteria: * Routine need for wheelchair or routine need for two canes or crutches * Diagnosis of another bleeding disorder such as von Willebrand Disease * Known event that would interfere with the scheduled CAJAS evaluations (e.g., elective joint surgery, vacation)

Locations (4)

Unnamed facility

Orange, California, United States

Unnamed facility

Aurora, Colorado, United States

Unnamed facility

Indianapolis, Indiana, United States

Unnamed facility

Portland, Oregon, United States

Outcomes

Primary Outcomes

Colorado Adult Joint Assessment Score (CAJAS)

Time frame: Up to 25 days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.